Profile
ACB ZTS HLN TAK TEVA NBIX
Company Name Aurora Cannabis Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $203.05M $77.92B $43.25B $42.20B $20.24B $15.52B
Employees 1.07K 14.10K 25.41K 49.28K 37.00K 1.70K
CEO Mr. Miguel Martin Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Kyle W. Gano Ph.D.
Ratings
ACB ZTS HLN TAK TEVA NBIX
Quant Rating Score 2 3 3 3 1 4
Quant Rating Sell Neutral Neutral Neutral Strong Sell Buy
Trading
ACB ZTS HLN TAK TEVA NBIX
Last Close $3.82 $172.71 $9.57 $13.7 $17.84 $153.29
High 52 $9.23 $199.94 $10.69 $15.08 $22.77 $153.29
Low 52 $0.38 $145.54 $8.01 $12.6 $12.01 $111.62
Price vs. 52 Week High -58.61 % -13.62 % -10.48 % -9.15 % -21.65 % 0 %
Price vs. 52 Week Low 905.26 % 18.67 % 19.48 % 8.73 % 48.54 % 37.33 %
Total Return
ACB ZTS HLN TAK TEVA NBIX
1 Month Return -10.12 % 6 % 0.31 % 3.47 % -19.06 % 12.3 %
3 Month Return -29.52 % -3.4 % -1.24 % -1.72 % -3.25 % 27.45 %
6 Month Return -37.89 % -4.07 % 4.59 % -1.3 % 2.35 % 8.28 %
9 Month Return -48.1 % 8.97 % 14.61 % 3.87 % 27.61 % 7.17 %
YTD Return -10.12 % 6 % 0.31 % 3.47 % -19.06 % 12.3 %
1 Year Return 905 % -8.04 % 16.71 % -6.16 % 47.44 % 9.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACB ZTS HLN TAK TEVA NBIX
Dividend Yield Percentage (TTM) - 1.04 % 1.65 % 4.59 % - -
Dividend Paid and Capex Coverage Ration (TTM) -4.52 % 2.1 % - 1.34 % 3.8 % 13.12 %
Dividend Per Share (TTM) - 1.8 % 0.06 % 192 % - -
Payout Ratio (TTM) - 31.44 % - 101.62 % - -
Growth
ACB ZTS HLN TAK TEVA NBIX
Asset Growth -9.46 % -4.28 % -2.18 % 8.25 % -1.2 % 37.27 %
Gross Profit Growth 304.26 % 3.7 % 5.84 % 1.76 % 9.65 % 26.06 %
Revenue Growth 15.86 % 5.74 % 4.09 % 5.87 % 6.17 % 26.76 %
Revenue 3 Year -60.7 % 31.98 % 13.9 % 33.13 % -6.91 % 71.93 %
Revenue 5 Year -98.47 % 53.64 % 32.87 % 103.83 % -23.33 % 308.36 %
Revenue 10 Year - 103.1 % 32.87 % 152.69 % -40.82 % 44100.16 %
EBIT Growth 81.73 % 6.27 % 9.37 % -56.36 % -84.52 % 0.76 %
Net Income Growth 73.87 % 10.88 % -1.04 % -54.56 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 96.44 % 47.55 % -8.67 % -61.74 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share 99.66 % 71.94 % 59.66 % 32.36 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share -392.1 % 404.24 % 59.66 % 35.42 % -133.42 % 470.4 %
Operating Income Growth 81.73 % 6.27 % 9.37 % -56.36 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) 40.85 % 23.06 % 1.79 % -26.69 % -13.96 % 14.88 %
Operating 3 Year CFG 88.4 % 14.12 % 48.8 % -29.25 % 10.09 % 62.6 %
Operating 5 Year CFG 99.5 % 37.69 % 166.36 % 118.64 % -48.98 % 275.6 %
Operating 10 Year CFG -1290.43 % 274.61 % 166.36 % 384.17 % -67.94 % 1000.37 %
EPS Growth 82.24 % 12.64 % - -54.92 % 76.42 % 59.01 %
EPS Diluted Growth 82.24 % 12.92 % - -54.86 % 76.42 % 58.33 %
Book Value Per Share -20.79 % 15.25 % 1.35 % 13.54 % -7.25 % 28.15 %
Share Holder 3 Year Equity Growth Per Share -90.2 % 36.7 % -36.6 % 40.38 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share -99.82 % 139.55 % -39.41 % 41.33 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share 1073.53 % 476.36 % -39.41 % 195.14 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 102.58 % -100 % -
Debt Growth -53.94 % -16.5 % -9.43 % 10.53 % -6.53 % 62.95 %
Free Cash Flow Growth 33.21 % 22.25 % 1.67 % -31.4 % -19.19 % 11.99 %
Updated On 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
ACB ZTS HLN TAK TEVA NBIX
Gross Profit Margin TTM 53.99 % 68.87 % 60.68 % 55.23 % 49.84 % 98 %
Return on Assets TTM -5.25 % 16.93 % 3.26 % 1.99 % -2.38 % 10.92 %
Return on Equity TTM -8.36 % 47.99 % 6.54 % 4.04 % -14.6 % 15.68 %
Return on Capital Employed TTM -4.45 % 26.36 % 7.22 % 4.18 % 1.6 % 18.91 %
Net Income Per EBT TTM 113.07 % 79.65 % 65.38 % 108.74 % 176.38 % 73.98 %
EBT Per Ebit TTM 122.51 % 91.46 % 82.95 % 52.35 % -125.67 % 88.81 %
EBIT Per Revenue TTM -16.28 % 36.45 % 17.82 % 11.21 % 2.67 % 26.19 %
Cash Flow To Debt Ratio TTM -54.65 % 43.6 % - 16.58 % 9.63 % 189.5 %
Receivables Turnover TTM 4.3 6.49 5.27 6.3 4.84 4.66
Payables Turnover TTM 4.42 7.05 1.23 4.92 3.55 0.47
Inventory Turnover TTM 0.48 1.18 3.03 1.69 2.12 0.98
Fixed Asset Turnover TTM 66.34 % 259.93 % 604.62 % 240.84 % 277.85 % 664.93 %
Asset Turnover TTM 23.28 % 63.75 % 33.71 % 31.2 % 40.16 % 63.45 %
Operating Cash Flow Per Share TTM -1.21 6.5 - 528.88 1.64 4.71
Free Cash Flow Per Share TTM -1.47 5.1 - 321.24 1.21 4.35
Cash Per Share TTM 247.72 % 378.45 % 5.72 % 57241.03 % 292.94 % 1214.64 %
Operating Cash Flow Sales Ratio TTM -29.33 % 32.18 % - 18.42 % 11.07 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 122.1 % 78.37 % - 60.74 % 73.71 % 92.38 %
Cash Flow Coverage Ratios TTM -54.65 % 43.6 % - 16.58 % 9.63 % 189.5 %
Price To Free Cash Flows Ratio TTM -4.18 33.76 - 13.03 14.86 35.27
Price To Operating Cash Flows Ratio TTM -4.42 26.56 - 7.9 10.94 32.53
Price Cash Flow Ratio TTM -4.42 26.56 - 7.9 10.94 32.53
Income Statement (TTM)
ACB ZTS HLN TAK TEVA NBIX
Revenue $0.27B $8.54B $11.3B $4263.76B $16.54B $1.89B
Gross Profit $0.13B $5.83B $6.96B $2832.26B $8.06B $1.85B
Gross Profit Ratio 48.64% 68.28% 61.59% 66.43% 48.74% 97.9%
EBITDA $0.02B $3.69B $2.35B $874.6B $-0.3B $0.36B
Net Income $-0.07B $2.34B $1.05B $144.07B $-1.64B $0.25B
EPS Diluted -1.46 5.07 0.11 91.16 -1.43 2.47
Balance Sheet (MRQ)
ACB ZTS HLN TAK TEVA NBIX
Long Term Debt $0.05B $6.75B $8.8B $5029.93B $18.48B $0.26B
Total Liabilities $0.24B $9.3B $17.33B $7834.79B $35.35B $1.02B
Total Equity $0.6B $4.99B $16.73B $7274.01B $8.13B $2.23B
Total Investments $0B $0.02B $0.07B $445.7B $0.01B $1.63B
Total Debt $0.1B $6.76B $9.46B $4843.75B $20.15B $0.43B
Total Assets $0.84B $14.29B $34.06B $15108.79B $43.48B $3.25B
Cash Flow Statement (TTM)
ACB ZTS HLN TAK TEVA NBIX
Net Income $-0.06B $2.34B $1.11B $144.07B $-1.96B $0.25B
Inventory $0B $-0.36B $-0.13B $-115.74B $0B $0.01B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $0B
Operating Cash Flow $-0.07B $2.35B $2.1B $716.34B $1.25B $0.39B
Capital Expenditure $-0.02B $-0.73B $-0.34B $-480.73B $-0.5B $-0.03B
Related Stocks
Ticker Name Price
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.57
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.41
ALVOW Alvotech 2.48
AMPH Amphastar Pharmaceuticals, Inc. 36.37
AMRX Amneal Pharmaceuticals, Inc. 8.58
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 59.56
AQST Aquestive Therapeutics, Inc. 3.08
ASRT Assertio Holdings, Inc. 0.8255
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 7.69
AYTU Aytu BioPharma, Inc. 1.68
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ACB
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 3.39 2.12
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 77.52
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.015 33.05
VALT ETFMG Sit Ultra Short ETF 3.29 48.52
THCX The Cannabis ETF 3.84 16.5963
POTX Global X Cannabis ETF 1.13 5.15
TOKE Cambria Cannabis ETF 2.27 5.01
DFAI Dimensional International Core Equity Market ETF 0.000538 30.71
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 2.79 1.75
BAD B.A.D. ETF 2.16 11.91
DFIC Dimensional International Core Equity 2 ETF 0.000345 27.05
DFIS Dimensional International Small Cap ETF 0.002271 25.4
DFSI Dimensional International Sustainability Core 1 ETF 0 34.545
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.00185 7.548
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0 25.76
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.00038 5.142
DXIV Dimensional ETF Trust 0.00085629 50.2849
Unlock